# Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients

> **NCT02459288** · PHASE4 · UNKNOWN · sponsor: **Ping-Yen Liu** · enrollment: 80 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Chronic Kidney Disease
- End-Stage Renal Disease

## Interventions

- **DRUG:** Clopidogrel first
- **DRUG:** Ticagrelor first

## Key facts

- **NCT ID:** NCT02459288
- **Lead sponsor:** Ping-Yen Liu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459288, "Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02459288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*